dialysis Flashcards

1
Q

what are kidneys for?

A

 To filter blood
 Excretion
 Potassium metabolism
 Blood manufacture (EPO)
 Acid/base metabolism
 Salt/water/blood pressure
 Calcium metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how to measure excetion

A

 Glomerular filtration rate -
inulin
56-Cr-EDTA

 Creatinine

 eGFR – calculated from creatinine, age,
(race)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

creatinine an renal function

A

A raised creatinine (< 120)
often implies > 50% loss of
renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

kidney damage stagin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how to treat hyperkalaemia

A

• K+
- ECG monitor
• No p waves, broad QRS or worse - IV calcium.
10ml calcium gluconate. Repeat until
complexes normalise. Give glucose & insulin.
• Peaked T’s - Glucose & insulin. 10 units
Actrapid in 50ml 50% glucose over 30 minutes.
Give as bolus if no pump available.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

treat EPO depletion

A

 Responds to pharmacological doses of ESA
– Erythropoiesis stimulating agents

ESA:

 Recombinant products
 s/c monthly to 3 times a week
 risk of hypertension/hyerpviscosity
 functional iron deficiency
 iv iron
 expense and funding issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

when do you get poor ESA response?

A

 Intercurrent disease
 infection
 malignancy

 Functional iron deficiency
 Ferritin poor guide
 % hypochromasia
 Treat with INTRAVENOUS iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how to treat metabloic acidosis

A

 Consider treating with sodium bicarbonate
 may produce overload and hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

renal bone diseases

A

 Untreated:
 Osteomalacia and Rickets
 Tertiary hyperparathyroidism
 Ectopic calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

bone biochemistry

A

 measure:
 Ca2+
 PO4
 Alkaline Phosphatase
 PTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how to manage renal bone disease

A

 When eGFR < , check PTH
 Treat if PTH > twice normal
 If phosphate is high, give phosphate binders
with food
 When phosphate is controlled or if normal, give
vitamin D analogue daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

chronic implications of renal impairment

A

 Progression to end-stage renal failure
 Hypertension
 Renal bone disease
 Anaemia
 Acidosis
 Psychological
 Fluid balance (overload/dehydration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

therapetic options

A

 Haemodialysis
 Peritoneal dialysis
 Transplantation
 Conservative therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CAPD

A
Continuous Ambulatory
 Peritoneal Dialysis (CAPD)

 4 x 2 litre exchanges every day
 Can be done anywhere
 Less fluid restriction
 Fewer dietary restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

malnutrition

A

 decreased intake
 uraemia/inadequate
dialysis
 depression
 absorbed glucose
(CAPD)
 abdominal fullness
(CAPD)
 altered taste
 haemodialysis

 intercurrent illness

 anaemia

 acidosis

 loss of protein in CAPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

complications of dialysis

A

 infection and
immunosuppression
 line/cannula infections
 Clostridium difficile
 blood borne viruses

 skin
 pruritis
 nodular prurigo
 dry skin
 pigmentation

 Hypertension
 Volume
 pre-existing condition
 calcium
 non-volume dependent
hypertension

 Cardiovascular
 left ventricular
hypertrophy
 Vascular calcification
 ischaemic heart disease
 sudden cardiac death

 renal bone disease
 bone pain
 acute hot joint - pseudogout
 pathological fractures
 secondary hyperparathyroidism
 tertiary hyperparathyroidism
 ectopic calcification

17
Q

can we determin who will not benefit from renal replacement therapy:?

A

Functional status (Karnovsky?)
Comorbidity and associated
prognosis

18
Q

NSF standard 14

A

Each person approaching established renal
failure is given timely and understandable
information about their prognosis and the
choice of therapies available to them
including the option of choosing not to
dialyse. They are made aware of the relative
burdens and benefits of the different types of
dialysis

19
Q

renal failure symtpoms near the end of life?

A

 Anorexia, N+V, dry mouth, ammonia taste,
breath smells of urine, hiccups, myoclonic
jerks, constipation, diarrhoea ( uraemia )
 SOB, Oedema ( fluid overload )
 Itch ( multifactorial )
 Tiredness ( anaemia, uraemia, cachexia)
 Gastric problems ( gastrin levels )
 Psychosocial problems

20
Q
A